Cargando…

Monocytic Subsets Impact Cerebral Cortex and Cognition: Differences Between Healthy Subjects and Patients With First-Episode Schizophrenia

Monocytes are a highly heterogeneous population subcategorized into classical, intermediate and nonclassical subsets. How monocytes and their subsets may shape brain structures and functions in schizophrenia remains unclear. The primary goal of this cross-sectional study was to investigate monocytic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Song, Fan, Fengmei, Xuan, Fang-Ling, Yan, Ling, Xiu, Meihong, Fan, Hongzhen, Cui, Yimin, Zhang, Ping, Yu, Ting, Yang, Fude, Tian, Baopeng, Hong, L. Elliot, Tan, Yunlong, Tian, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309358/ https://www.ncbi.nlm.nih.gov/pubmed/35898501 http://dx.doi.org/10.3389/fimmu.2022.900284

Ejemplares similares

Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls
por: Chen, Song, et al.
Publicado: (2022)

Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls
por: Shi, Jing, et al.
Publicado: (2022)

TGF-β1 is associated with deficits in cognition and cerebral cortical thickness in first-episode schizophrenia
por: Pan, Shujuan, et al.
Publicado: (2022)

Childhood trauma and cognitive deficits in patients with schizophrenia: mediation by orbitofrontal cortex H-shaped sulci volume
por: Wang, Leilei, et al.
Publicado: (2022)

Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia
por: Huang, Junchao, et al.
Publicado: (2021)

Abnormal amygdala subregional-sensorimotor connectivity correlates with positive symptom in schizophrenia
por: Zhang, Meng, et al.
Publicado: (2020)

CSF1R regulates schizophrenia-related stress response and vascular association of microglia/macrophages
por: Yan, Ling, et al.
Publicado: (2023)

Associations of the serum kynurenine pathway metabolites with P50 auditory gating in non-smoking patients with first-episode schizophrenia
por: Yang, Qingyan, et al.
Publicado: (2022)

Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
por: Xiu, Meihong, et al.
Publicado: (2023)

The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure
por: Pan, Shujuan, et al.
Publicado: (2021)

The effect of transcranial direct current stimulation combined with working memory training on working memory deficits in schizophrenic patients: study protocol for a randomized controlled trial
por: Zhu, Xiaolin, et al.
Publicado: (2022)

A bottom-up model of functional outcome in schizophrenia
por: Luo, Hongge, et al.
Publicado: (2021)

Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic
por: Ma, Botao, et al.
Publicado: (2023)

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
por: Chen, Xiaofang, et al.
Publicado: (2023)

Who will benefit from computerized cognitive remediation therapy? Evidence from a multisite randomized controlled study in schizophrenia
por: Tan, Shuping, et al.
Publicado: (2020)

Replenished microglia partially rescue schizophrenia-related stress response
por: Yan, Ling, et al.
Publicado: (2023)

Resting-state functional connectivity of neural circuits associated with primary and secondary rewards in patients with bipolar disorder
por: Shi, Jing, et al.
Publicado: (2020)

Computerized cognitive remediation therapy effects on resting state brain activity and cognition in schizophrenia
por: Fan, Fengmei, et al.
Publicado: (2017)

Brain Correlates of Self-Evaluation Deficits in Schizophrenia: A Combined Functional and Structural MRI Study
por: Tan, Shuping, et al.
Publicado: (2015)

Glial receptor PLXNB2 regulates schizophrenia-related stress perception via the amygdala
por: Xuan, Fang-Ling, et al.
Publicado: (2022)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement
por: Yu, Ting, et al.
Publicado: (2018)

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
por: Su, Xiuru, et al.
Publicado: (2021)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

The Ontogeny of Monocyte Subsets
por: Wolf, Anja A., et al.
Publicado: (2019)

Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
por: Wu, Zhiwei, et al.
Publicado: (2021)

Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory
por: Kochunov, Peter, et al.
Publicado: (2020)

Phenotypic and functional alterations of monocyte subsets with aging
por: Cao, Yu, et al.
Publicado: (2022)

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017)

Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
por: Lang, Xiaoe, et al.
Publicado: (2023)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
por: Wang, Keqiang, et al.
Publicado: (2022)

Aging of classical monocyte subsets
por: Goodridge, Helen S.
Publicado: (2023)

Monocyte subsets and monocyte-related chemokines in Takayasu arteritis
por: de Aguiar, Mariana Freitas, et al.
Publicado: (2023)

SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia
por: Udawela, M, et al.
Publicado: (2015)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Anterior cingulate cortex-related connectivity in first-episode schizophrenia: a spectral dynamic causal modeling study with functional magnetic resonance imaging
por: Cui, Long-Biao, et al.
Publicado: (2015)

Abnormal cortisol profile during psychosocial stress among patients with schizophrenia in a Chinese population
por: Zhu, Xiaoyu, et al.
Publicado: (2022)

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia
por: Lang, Xiao-E, et al.
Publicado: (2018)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfhnpt0kkt2bd42vr0ommhh523